• U.S. Stocks Fall on Concern Fed Will Scale Back Stimulus
  • Pfizer to Split Off Rest of Zoetis Animal Health Business
  • BioMarin Gains on Prospects for Experimental Cancer Drug
  • New Flu Vaccine Beats Current Products in Animal Testing
  • Europe Stocks Little Changed as Bernanke Backs Bond Plan
  • Novartis Ramps Up Alzheimer’s Drug Pursuit as Rivals Fail
  • Hedge Funds Trail S&P 500 by 10 Percentage Points, Goldman Says
  • India Said to Seek Review of U.S. Court Ruling Papers on Ranbaxy
  • Swiss Billionaires Buy Merck Geneva Building for Biotech Campus
  • The Top Ten Stocks for Wednesday, May 22
  • Apple Got No Sweetheart Accord on Corporate Tax Bill, Irish Say
  • Glaxo to Get Up to $200 Million for U.S. Research
  • Kasowitz Benson, Eversheds, Latham: Business of Law
  • Google Joins Apple Avoiding Taxes With Stateless Income
  • Merck to Buy Back $5 Billion of Its Shares From Goldman
« Previous 1 2 3 4 5 Next »